Award will help advance neuroscience technologies aimed at improving cognitive wellness
Washington University receives NSF Engines Development Award (Links to an external site)
Category: School — Medicine
Needleman innovation program seeks proposals for therapeutic development (Links to an external site)
Up to $4 million in funding available to pursue ‘investigational new drug’ status
Scientists aim to develop vaccine against all deadly coronaviruses (Links to an external site)
Washington University School of Medicine in St. Louis scientists Michael S. Diamond, MD, PhD, and Sean Whelan, PhD, lead a team working to minimize the risk of another devastating coronavirus pandemic by designing a vaccine that reduces sickness and death caused by all potentially deadly coronaviruses, including ones that have not yet affected people. The research is supported by an $8 million grant from the National Institute for Allergy and Infectious Diseases of the National Institutes of Health (NIH).
Imaging tech produces real-time 3D maps of uterine contractions during labor (Links to an external site)
Noninvasive technique could shed light on preterm birth
WashU Medicine reaches new heights as it climbs to No. 3 in NIH research funding (Links to an external site)
Research flourishes despite the immense challenges of the pandemic
Gordon receives Dr. Paul Janssen Award for Biomedical Research (Links to an external site)
‘Father of the field’ honored for gut microbiome research
Nasal COVID-19 vaccine approved in India based on Washington University technology (Links to an external site)
The world’s first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International Limited in India.